Lifemark, the cash strapped Luxembourg-based backer of Keydata bonds, is embroiled in a multi-millon dollar legal battle in the US Court of Appeal.
The row is over a $10m US traded life-settlement policy - the asset class which underlies the Lifemark fund - bought by the company in 2007 for $1.9m. American attorney Arthur Kramer bought several policies late in his life, assigned them to two trusts, named his children as beneficiaries and then directed them to sell their interest in the trusts to investors for cash. Following his death, Kramer's widow Alice is claiming the death benefits should go to the estate, not Lifemark investors. Investors who filed claims with the insurers have been told the policies are void. The...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes